David Adelman

David Adelman serves as the Vice President of Strategy & Program Management at Edwards Lifesciences since August 2018, leading the global strategy for the TMTT business unit focused on mitral and tricuspid valve disease. Adelman's extensive tenure at Edwards Lifesciences spans from 1999 to 2018 in various leadership roles, including Vice President of Strategy, Market Access & New Initiatives for EEMEA, and Vice President of Healthcare Solutions, where a new service model was developed to enhance patient access. Additional positions held include General Manager roles in critical care and cardiovascular divisions, where significant revenue growth and strategic restructuring were achieved. Prior experience includes a Director position in Business Development at Baxter Healthcare, overseeing strategy for multiple divisions. David Adelman holds a Master's Degree in International Economics & Affairs from The Johns Hopkins University and a Bachelor's Degree in Economics and Public Policy Studies from Duke University.